Resultados da pesquisa - Steven J. Charlton

Refinar resultados
  1. 1
    Agonist efficacy and receptor desensitization: from partial truths to a fuller picture

    Agonist efficacy and receptor desensitization: from partial truths to a fuller picture Por Steven J. Charlton

    Publicado em 2009
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Long‐lasting target binding and rebinding as mechanisms to prolong <i>in vivo</i> drug action

    Long‐lasting target binding and rebinding as mechanisms to prolong <i>in vivo</i> drug action Por Georges Vauquelin, Steven J. Charlton

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands

    Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands Por Georges Vauquelin, Steven J. Charlton

    Publicado em 2013
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays

    Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays Por Steven J. Charlton, Georges Vauquelin

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Slow receptor dissociation is not a key factor in the duration of action of inhaled long‐acting β<sub>2</sub>‐adrenoceptor agonists

    Slow receptor dissociation is not a key factor in the duration of action of inhaled long‐acting β<sub>2</sub>‐adrenoceptor agonists Por David A. Sykes, Steven J. Charlton

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M<sub>3</sub>receptor

    Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M<sub>3</sub>receptor Por Mark R. Dowling, Steven J. Charlton

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?

    Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path? Por Martin C. Michel, Steven J. Charlton

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  8. 8
    Miniaturized Receptor Binding Assays: Complications Arising from Ligand Depletion

    Miniaturized Receptor Binding Assays: Complications Arising from Ligand Depletion Por Clare M. Scaramellini Carter, Juliet Leighton-Davies, Steven J. Charlton

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Evidence that P2Y<sub>4</sub> nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP

    Evidence that P2Y<sub>4</sub> nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP Por Simon Harper, Tania E. Webb, Steven J. Charlton, Leong L. Ng, Michael R. Boarder

    Publicado em 1998
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    A common intracellular allosteric binding site for antagonists of the CXCR2 receptor

    A common intracellular allosteric binding site for antagonists of the CXCR2 receptor Por Karolina Salchow, ME Bond, SC Evans, NJ Press, Steven J. Charlton, PA Hunt, ME Bradley

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    PPADS and suramin as antagonists at cloned P<sub>2Y</sub>‐ and P<sub>2U</sub>‐purinoceptors

    PPADS and suramin as antagonists at cloned P<sub>2Y</sub>‐ and P<sub>2U</sub>‐purinoceptors Por Steven J. Charlton, Colin A. Brown, Gary A. Weisman, John T. Turner, Laurie Erb, Michael R. Boarder

    Publicado em 1996
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Cloned and transfected P2Y<sub>4</sub> receptors: characterization of a suramin and PPADS‐insensitive response to UTP

    Cloned and transfected P2Y<sub>4</sub> receptors: characterization of a suramin and PPADS‐insensitive response to UTP Por Steven J. Charlton, Colin A. Brown, Gary A. Weisman, John T. Turner, Laurie Erb, Michael R. Boarder

    Publicado em 1996
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

    The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease Por Philippa R Dale, Hana Černecká, Martina Schmidt, Mark R. Dowling, Steven J. Charlton, Michael Pieper, Martin C. Michel

    Publicado em 2014
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  14. 14
    Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors

    Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors Por David A. Sykes, Holly Moore, Lisa A. Stott, Nicholas D. Holliday, Jonathan A. Javitch, J. Robert Lane, Steven J. Charlton

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

    Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy Por David A. Sykes, Michelle Bradley, Darren Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois, Steven J. Charlton

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization

    Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization Por David A. Sykes, Darren Riddy, Craig Stamp, Michelle Bradley, Neil McGuiness, Afrah Sattikar, Danilo Guerini, Inês S. Rodrigues, Albrecht Glaenzel, Mark R. Dowling, Florian Müllershausen, Steven J. Charlton

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35

    The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35 Por Amanda E. Mackenzie, Gianluigi Caltabiano, Toby Kent, Laura Jenkins, Jennifer E. McCallum, Brian D. Hudson, Stuart A. Nicklin, Lindsay Fawcett, Rachel Markwick, Steven J. Charlton, Graeme Milligan

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization

    μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization Por Jamie McPherson, Guadalupe Rivero, Myma Baptist, Javier Llorente, Suleiman Al‐Sabah, Cornelius Krasel, William L. Dewey, Christopher Bailey, Elizabeth M. Rosethorne, Steven J. Charlton, Graeme Henderson, Eamonn Kelly

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor

    Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor Por Guadalupe Rivero, Javier Llorente, Jamie McPherson, Alex Cooke, Stuart J. Mundell, Craig A. McArdle, Elizabeth M. Rosethorne, Steven J. Charlton, Cornelius Krasel, Christopher Bailey, Graeme Henderson, Eamonn Kelly

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Mass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor

    Mass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor Por Hsin‐Yung Yen, Idlir Liko, Wanling Song, Parth Kapoor, Fernando Almeida, Joanna Toporowska, Karolina Gherbi, Jonathan T. S. Hopper, Steven J. Charlton, Argyris Politis, Mark S.P. Sansom, Ali Jazayeri, Carol V. Robinson

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: